Wednesday, July 17, 2019

Cannabis use and markers of systemic inflammation: The Coronary Artery Risk Development in Young Adults Study

Bad research. Most likely any bad effects were from smoking rather than cannabis.  

My 13 reasons for marijuana use post-stroke.  

Don't follow me, I'm not medically trained and I don't have a Dr. in front of my name. 

Just returned from Canada and you can buy specific THC potencies from drugstores.  Did not return with any, gave leftovers to Canadians at the campground. The customs agents asked if any marijuana or marijuana products were being brought across. No dogs were seen.

Cannabis use and markers of systemic inflammation: The Coronary Artery Risk Development in Young Adults Study

American Journal of MedicineAlshaarawy O, et al. | July 16, 2019

Via The Coronary Artery Risk Development in Young Adults study, a cohort of 5,115 African-American and Caucasian males and females were recruited in 1985-1986 and followed up for over 25 years, with recurring measurements of cannabis use, researchers investigated immunomodulation attributable to cannabis, as demonstrated in levels of fibrinogen, C-reactive protein (CRP), and interleukin-6. Current cannabis use had no correlation with any of the biomarkers studied, even after adjusting for potential confounding variables, vs never users. Previous cannabis use had an inverse correlation with fibrinogen levels; the correlations were smaller for serum CRP. A modest inverse correlation among previous cannabis use and fibrinogen was seen. In order to examine the immunomodulatory impacts of cannabis relative to various cannabis preparations and modes of use, more studies are required.
Read the full article on American Journal of Medicine

No comments:

Post a Comment